Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure of human coagulation activated factor VII.

E Persson1

  • 1Department of Tissue Factor/Factor VII Research, Novo Nordisk A/S, Måløv, Denmark. egpe@novo.dk

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|June 13, 2000
PubMed
Summary

Activated factor VII (FVIIa) is a protease crucial for blood clotting. Its structure reveals why it needs tissue factor to become fully active, offering insights into coagulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey: comment.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Assessment of dosimetric impact of system specific geometric distortion in an MRI only based radiotherapy workflow for prostate.

Physics in medicine and biology·2017
Same author

Dose related effects of LPS on endometrial epithelial cell populations from dioestrus cows.

Animal reproduction science·2016
Same author

Low degree of satisfactory individual pain relief in post-operative pain trials.

Acta anaesthesiologica Scandinavica·2016
Same author

Overestimation of N-glycoPEGylated factor IX activity in a one-stage factor IX clotting assay owing to silica-mediated premature conversion to activated factor IX.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Tissue factor activates allosteric networks in factor VIIa through structural and dynamic changes.

Journal of thrombosis and haemostasis : JTH·2014

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Hematology

Background:

  • Activated factor VII (FVIIa) is a serine protease initiating blood coagulation.
  • FVIIa is generated from factor VII (FVII) cleavage but remains in a zymogen-like state.
  • Unlike other proteases, FVIIa requires tissue factor (TF) for efficient catalytic activity.

Purpose of the Study:

  • To determine the structure of free FVIIa lacking the gamma-carboxyglutamic acid (Gla) domain.
  • To understand the molecular basis for FVIIa's low activity without TF.
  • To investigate conformational changes upon TF binding.

Main Methods:

  • X-ray crystallography to determine the structure of FVIIa.
  • Structural analysis to compare free FVIIa with TF-bound FVIIa.

Related Experiment Videos

Main Results:

  • The structure of free FVIIa (without Gla domain) was determined.
  • The structure provides insights into FVIIa's zymogen-like state and low basal activity.
  • Conformational differences between free and TF-bound FVIIa were elucidated.

Conclusions:

  • The structure of free FVIIa explains its dependence on TF for full catalytic function.
  • Understanding these molecular mechanisms is key for developing coagulation-related therapies.
  • Further research into TF-FVIIa interactions can inform drug design.